NIH-funded research Career grant

Identifying diagnostic errors in high-risk patients after emergency department visits

Official title: Detecting and characterizing diagnostic errors among high-risk patients discharged from the emergency department

Funded at Cedars-Sinai Medical Center · NIH-11079595 · Data updated 2026-11-12

This study is looking to find out how to spot and understand mistakes in diagnoses for older patients or those with ongoing health issues after they leave the emergency room, and it aims to help make sure everyone gets safer and better care.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startMay 1, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$150,921
NIH project number5K08HS029534-02
Project IDNIH-11079595 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are high-risk patients, particularly older adults or those with multiple chronic conditions, who have been discharged from an emergency department.

Less likely to help

Patients who are not considered high-risk or who do not have significant health concerns may not benefit from this research.

What this research studies

This research investigates how to detect and understand diagnostic errors that occur among high-risk patients who are discharged from emergency departments (EDs). It aims to enroll 300 patients, focusing on those who are older or have chronic health conditions, to gather data through follow-up calls, questionnaires for healthcare providers, and reviews of medical records. By identifying these errors and their consequences, the research seeks to improve patient safety and the quality of care in EDs.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of diagnostic errors in emergency departments, leading to better health outcomes for patients.

How similar studies have gone: Previous research has indicated that improving detection of diagnostic errors in healthcare settings can lead to enhanced patient safety, suggesting that this approach has potential for success.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Berdahl, Carl Thomas — Cedars-Sinai Medical Center
  • Study coordinator: Berdahl, Carl Thomas

Related research

Other NIH-funded projects on the same topics.

  • Lipid signals that control acetyl-CoA and fat metabolism in NAFLD

    A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591466

  • Them1’s role in fat metabolism and MASLD progression

    Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591395

  • Biomarker-guided Immunosuppression in Kidney Transplant Patients

    A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11550940

  • Alpha5 integrin's role in ALS: how a cell switch worsens disease

    Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

  • Chlamydia pneumoniae infection and Alzheimer's disease progression

    This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11538116

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.